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Objective: The purpose of this study was to explore the relationships between perceived social support
and retention in Chinese mainland patients receiving methadone maintenance treatment (MMT).
Methods: This was a cross-sectional two-year follow-up study. The data collected included patients'
baseline characteristics, perceived social support and retention in MMT.
Results: A total of 1212 patients completed the cross-sectional survey; 809 (66.7%) had good perceived
social support and 458 (37.8%) had experienced readmissions. With and without controlling for baseline
characteristics, past retention had no signiﬁcant inﬂuence on perceived social support. By the end of the
follow-up, 527 (43.5%) patients had terminated MMT. The patients without good perceived social support
were more likely to terminate treatment than those with good perceived social support [hazard ratio:
1.31, 95% conﬁdence interval: 1.10, 1.57; 1.25 (1.04, 1.51)] regardless of their baseline characteristics and
past retention.
Conclusions: Retention, thus, had no signiﬁcant inﬂuence on perceived social support in MMT, whereas
good perceived social support was a strong protective predictor of retention.
© 2016 Shanxi Medical Periodical Press. Production and hosting by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Drug abuse has been prevalent in China for many years. Ofﬁcial
statistics indicate that the number of registered drug users has
increased from 70,000 in 1990 to 2.22 million in 2013,1,2 with
approximately 80% of them dependent on opiates.3 Compared with
the general population, opiate dependents are known to encounter
a much higher risk of infectious diseases and death and to expe-
rience numerous psychosocial problems.4 Opiate use thus
adversely affects individuals and societies and has become a major
public health and social problem.
Methadone maintenance treatment (MMT) is a long-term
opiate replacement therapy that consists of daily methadone
administration.5 In China, MMT was initiated as a pilot program in
eight clinics serving 1029 drug users in 20046 and subsequentlyS Major Project of China (NO.
al Periodical Press.
Production and hosting by Elsevexpanded to 748 clinics serving 360,000 drug users in 2012.7 MMT
is one component of harm reduction programs, which have the
additional intention of reducing concomitant infections and high-
risk behaviors resulting from injecting drugs and sharing nee-
dles.8,9 However, due to its alternative characteristics and long-
term treatment requirements, the majority of MMT patients
cannot sustain long-term treatment for various reasons, the most
important of which is social support.10
Social support is the perception and actuality that one is cared
for, has access to assistance from other people, and is part of a
supportive social network. These supportive resources can be
emotional (e.g., nurturance), tangible (e.g., ﬁnancial assistance),
informational (e.g., advice), companionship (e.g., sense of
belonging), or intangible (e.g., personal advice).11 Because social
support has a buffering effect on stressful life events and
depression12e14 as well as substantial impacts on treatment out-
comes,15e18 it is very important to understand the status of social
support in MMT patients, particularly their perceived social
support.19e22
Perceived social support has been conceptualized as a function
of beliefs about one's self-worth and the availability andier B.V. This is an open access article under the CC BY-NC-ND license (http://
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support, family relationships, families' supportive attitudes toward
MMT, and living on support from family or friends to all be sig-
niﬁcant predictors of retention in MMT.10,24 However, few studies
have explored the inﬂuence of perceived social support on reten-
tion in MMT patients.25 Long-term MMT has shown a satisfactory
effect on improving the proportion of patients with a good patient-
family relationship26; whether MMT retention also positively in-
ﬂuences perceived social support is still unclear.
The purpose of this study was to explore the relationships be-
tween perceived social support and retention in Chinese mainland
patients undergoing MMT.We tested two hypotheses: (1) retention
inﬂuences perceived social support and (2) perceived social sup-
port predicts retention. To our knowledge, this is the ﬁrst study to
focus on the relationship between perceived social support and
retention in the same sample of MMT patients. The results of this
study will provide a better understanding of the relationship be-
tween perceived social support and retention in MMT patients and
provide evidence for social support management and intervention
in MMT patient populations.
2. Methods
2.1. Ethics statement
The study protocol was reviewed and approved by the Human
Research Ethics Committee of Xi'an Jiaotong University. Written
informed consent was obtained from each recruited patient before
the questionnaire was applied.
2.2. Design
This study was a cross-sectional two-year follow-up study.
2.3. Subjects and data collection
The subjects were admitted patients of the two largest MMT
clinics in Xi'an, China. One is privately funded and the other is
publicly funded. Subjects were included if they were18 years or
over and spoke Chinese. If the patients had cognitive disorders or
refused to provide written informed consent, they were excluded.
The data were collected in March of 2012 with a two-year
follow-up by the end of March of 2014. The recruited MMT pa-
tients participated in individual face-to-face interviews that were
conducted by trained interviewers in a quiet and well-lit room. The
data collected included baseline information, perceived social
support, and retention in MMT.
2.4. Baseline information
The baseline information included data on participants' socio-
demographics (nine items), drug use history (two items), and
family's social function (three items).
2.5. Multiple scale of perceived social support (MSPSS)
Perceived social support was evaluated using the MSPSS, which
is a 12-item self-report questionnaire designed to measure the
perception of an individual's level of support from family, friends,
and signiﬁcant others.27 Each item is rated on a seven-point Likert
scale ranging from 1 (very strongly disagree) to 7 (very strongly
agree). The total score is calculated by summing the results of all the
items, whereas the individual subscales are calculated by summing
the responses of the items in each of the three dimensions. The
possible scores range from 4 to 28 for each subscale and 12e84 forall items, with a total score over 50 representing good perceived
social support.28 The original MSPSS has shown good internal
reliability across subject groups; the three-factor model (i.e., family,
friends, and signiﬁcant others) has been strongly supported by
factorial validity, particularly the family and signiﬁcant others di-
mensions.29 Huang et al28 translated the MSPSS into Chinese and
validated the instrument in cancer patients, indicating sound psy-
chometric properties. In this study, the Cronbach's a of the overall
MSPSS was 0.92, with subscale coefﬁcients of 0.88, 0.89, and 0.84
for family, friends, and signiﬁcant others, respectively.30
2.6. Retention
According to the design, retention was assessed by readmission
(yes or no), past treatment time (days; i.e., past retention), treat-
ment termination (yes or no), and follow-up treatment time (days;
i.e., follow-up retention). Readmission was used to identify pa-
tients' termination history since their ﬁrst admission to MMT. Past
treatment time represented the number of days that the patients
had participated in MMT between their ﬁrst MMT admission date
and March 31, 2012. Treatment termination was included to assess
whether the patient had been consecutively retained in MMTat the
end of the two-year follow-up. Patients who did not take metha-
done for seven consecutive days (Manual of Comprehensive Inter-
vention for HIV/AIDS in Drug Users with Community Methadone
Maintenance Treatment, 2011) were regarded as being terminated.
Finally, the follow-up treatment time indicated the actual number
of days that patients had received MMT between April 1, 2012 and
March 31, 2014.
2.7. Data analyses
A database was built using Epidata 3.1, and two different in-
dividuals double-entered the data to capture data entry errors.
Frequencies and percentages were used for categorical variables,
and means and standard deviations were used for continuous
variables. Logistic regression analysis was performed to identify the
inﬂuence of past retention (i.e., readmission and past treatment
time) on perceived social support regardless of baseline informa-
tion (i.e., sociodemographics, drug history, and family social func-
tioning). Cox regression analysis was used to identify the inﬂuence
of perceived social support on retention at follow-up (i.e., termi-
nation and follow-up treatment time) with and without controlling
for baseline information and past retention. All statistical analyses
were completed using SPSS 20.0. A value of P < 0.05 (two-tailed)
was considered to be statistically signiﬁcant.
3. Results
Totally 1270 patients were eligible for the study; 1212 patients
completed the cross-sectional questionnaire survey, with 851
(70.2%) from the privately funded clinic and 361 (29.8%) in the
publicly funded clinic. The patients well understood the questions
in the face-to-face interviews and fully completed the question-
naires. Each interview lasted for approximately 20e25 min. Fifty-
eight (4.6%) patients (28 in the privately funded clinic and 30 in
the publicly funded clinic) were excluded because they refused to
provide written informed consent.
3.1. Baseline information
The patients were aged 42.48 ± 6.24 (range: 21e65) years, 934
(77.1%) were men. The majority of the patients had received sec-
ondary education (n ¼ 987, 81.4%), were married (n ¼ 705, 58.2%),
had children (n¼ 840, 69.3%), were employed (n¼ 618, 51.0%), lived
K.-N. Zhou et al. / Chinese Nursing Research 3 (2016) 11e15 13with family (n ¼ 898, 74.1%), had an average monthly income
(Chinese yuan) of less than 1000 in the past 12 months (n ¼ 708,
58.4%), and had a chronic disease (n ¼ 616, 50.8%). The average age
of initial drug use was 28.41 ± 7.35 (range: 14e52) years, and
approximately 20% of the patients reported using drugs in the past
month (n ¼ 237, 19.6%). Over 60% of the patients had good family
relationships (n ¼ 820, 67.7%) and family/friends who supported
MMT (n¼ 1065, 87.9%), whereas 62.5% (n¼ 757) of the patients did
not usually have contact with friends (Table 1).3.2. Past retention
Following their ﬁrst admission to MMT, readmission patients
accounted for 37.8% (n ¼ 458) of the study population. The average
past treatment time was 1057.37 ± 517.05 (range: 1e1984) days;
there were 171 (14.1%), 221 (18.2%), 157 (13.0%), 183 (15.1%), andTable 1
Patient's baseline information (n ¼ 1212; n, %).
Baseline information Proﬁle
Sociodemographics
Age (years) (mean ± SD) 42.48 ± 6.24
 30 61 (5.0)
31e40 357 (29.5)
41e50 711 (58.7)
> 50 83 (6.8)
Gender
Male 934 (77.1)
Female 278 (22.9)
Education level
Primary and below 141 (11.6)
Secondary 987 (81.4)
Tertiary 84 (6.9)
Marital status
Married 705 (58.2)
Other 507 (41.8)
Having children
Yes 840 (69.3)
No 372 (30.7)
Employment status
Unemployed 594 (49.0)
Employed 618 (51.0)
Living with family
Yes 898 (74.1)
No 314 (25.9)
Average monthly income (past 12 months) (Chinese yuan)
<1000 708 (58.4)
1000e3000 307 (25.3)
>3000 197 (16.3)
Chronic disease
Yes 616 (50.8)
No 596 (49.2)
Drug use history
Initial drug use age (years) (mean ± SD) 28.41 ± 7.35
 20 223 (18.4)
21e30 613 (50.6)
31e40 315 (26.0)
> 40 61 (5.0)
Drug use over the past month
Yes 237 (19.6)
No 975 (80.4)
Family social function
Good family relationship
Yes 820 (67.7)
No 392 (32.3)
Routine contact with friends
Yes 455 (37.5)
No 757 (62.5)
Family/friends who support MMT
Yes 1065 (87.9)
No 147 (12.1)480 (39.6%) patients who maintained MMT for less than one year,
one year, two, three, and four years and above, respectively. These
data were not tabulated.
3.3. Perceived social support and its relationship with past
retention
The average of the overall MSPSS score was 55.06 ± 12.40, with
66.7% (n ¼ 809) of the patients reporting good perceived social
support. Patients reported the highest level of support from their
family (19.48 ± 4.65), followed by support from signiﬁcant others
(18.16 ± 4.60) and friends (17.42 ± 5.08). These data were not
tabulated.
Without adjusting for baseline characteristics, readmission and
past treatment time did not inﬂuence perceived social support.
After controlling for baseline information, neither readmission
[0.98 (0.75, 1.27)] nor past treatment time [1.03 (0.95, 1.12)] inﬂu-
enced perceived social support (P ¼ 0.86, P ¼ 0.49) (Table 2).
3.4. Follow-up retention and its relationship with perceived social
support
A total of 1211 patients completed the two-year follow-up, with
684 (56.4%) maintaining and 527 (43.5%) terminating MMT. The
follow-up treatment timewas 598.95 ± 207.12 (range: 4e730) days.
One patient was lost to follow-up because of transferring to another
MMT clinic. These data were not tabulated.
Without adjusting for their baseline characteristics and past
retention, the patients who did not report good perceived social
support were 1.31 times more likely to terminate treatment than
those with good perceived social support (hazard ratio: 1.31, 95%
conﬁdence interval: 1.10, 1.57, P ¼ 0.003). After controlling for
baseline information and past retention, the patients without good
perceived social support were 1.21 times more likely to terminate
treatment than those with good perceived social support (1.21
[1.08, 1.47], P ¼ 0.01; Table 3).
4. Discussion
This study explored the relationships between perceived social
support and retention in Chinesemainland patients receivingMMT.
Based on the overall MSPSS score, over 60% of the patients had good
perceived social support, indicating that MMT patients have posi-
tive perceptions of support from family and social contexts.27
Regarding the three MSPSS subscales, patients had the highest
level of perceived support from their family, followed by support
from signiﬁcant others and friends, demonstrating that family was
the most important source of support for MMT patients. This is
consistent with the results of an earlier study on MMT patients31;
however, it differs from the ﬁnding among female MMT patients
who have experienced intimate partner violence that signiﬁcant
others provide the highest level of perceived social support.32 This
difference is most likely due to the different participant charac-
teristics. Therefore, the order of the three sources of perceived so-
cial support (i.e., family, friends, and signiﬁcant others) in MMT
patients with different characteristics needs further exploration.
With and without controlling for baseline characteristics,
neither readmission nor past treatment time signiﬁcantly inﬂu-
enced the patients' perceived social support. Thus, the ﬁrst hy-
pothesis that retention inﬂuences perceived social support was not
supported by the study results. These ﬁndings indicate that
termination history and past treatment days during MMT had no
signiﬁcant association with perceived social support and that MMT
did not improve patients' perceptions of support from family,
friends, or signiﬁcant others. Although a previous study has
Table 2
Inﬂuence of retention on perceived social support: (Logistic regression analysis) (n ¼ 1212).
Independent variables* B SE Wald c2 P OR (95% CI)
Univariate analysis
Readmission 0.09 1.25 0.52 0.47 0.91 (0.72, 1.17)
Past treatment time (days) 0.02 0.04 0.27 0.60 1.02 (0.94, 1.11)
Multivariate analysis
Age (years) 0.18 0.11 2.59 0.11 0.84 (0.68, 1.04)
Gender 0.13 0.16 0.63 0.43 0.88 (0.65, 1.20)
Education level 0.36 0.16 5.08 0.02 1.43 (1.05, 1.94)
Marital status 0.04 0.16 0.05 0.82 0.97 (0.71, 1.31)
Having children 0.43 0.16 7.05 0.01 0.65 (0.47, 0.89)
Employment status 0.28 0.15 3.39 0.07 0.76 (0.56, 1.02)
Living with family 0.51 0.16 10.43 0.00 1.66 (1.22, 2.25)
Average monthly income (past 12 months) (Chinese yuan) 0.20 0.11 3.28 0.07 0.82 (0.66, 1.02)
Chronic disease 0.15 0.13 1.27 0.26 0.86 (0.67, 1.11)
Initial drug use age (years) 0.21 0.09 4.96 0.03 0.81 (0.68, 0.98)
Drug use over the past month 0.17 0.16 1.09 0.30 0.85 (0.62, 1.16)
Good family relationship 0.42 0.15 8.23 0.00 1.52 (1.14, 2.03)
Routine contact with friends 0.65 0.16 17.53 0.00 1.92 (1.42, 2.61)
Family/friends who support MMT 0.46 0.19 5.79 0.02 1.58 (1.09, 2.28)
Readmission 0.03 0.14 0.03 0.86 0.98 (0.75, 1.27)
Treatment time (days) 0.03 0.04 0.48 0.49 1.03 (0.95, 1.12)
Notes: * The independent variables included all characteristics in Table 1: age (years:30¼ 1, 31e40¼ 2, 41e50¼ 3, >50¼ 4); gender (male¼ 1, female¼ 2); education level
(primary and below ¼ 1, secondary ¼ 2, tertiary ¼ 3); marital status (married ¼ 1, others ¼ 2); having children (yes ¼ 1, no ¼ 2); employment status (unemployed ¼ 1,
employed¼ 2); living with family (yes¼ 1, no¼ 2); averagemonthly income (past 12months; Chinese yuan: <1000¼ 1, 1000e3000¼ 2, >3000¼ 3); chronic disease (yes¼ 1,
no ¼ 2); initial drug use age (years:  20 ¼ 1, 21e30 ¼ 2, 31e40 ¼ 3, >40 ¼ 4); drug use over the past month (yes ¼ 1, no ¼ 2); good family relationship (yes ¼ 1, no ¼ 2);
routine contact with friends (yes ¼ 1, no ¼ 2); family/friends who support MMT (yes ¼ 1, no ¼ 2); readmission (yes ¼ 1, no ¼ 2); and past treatment time (days: < 365 ¼ 1,
365e729 ¼ 2, 730e1094 ¼ 3, 1095e1459 ¼ 4, 1460 ¼ 5).
Table 3
Inﬂuence of perceived social support on retention in MMT at follow-up: Cox regression analysis (n ¼ 1211).
Covariates* B SE Wald c2 P HR (95%CI)
Univariate analysis
Good perceived social support 0.27 0.09 8.92 0.00 1.31 (1.10, 1.57)
Multivariate analysis
Age (years) 0.19 0.06 8.47 0.00 0.79 (0.67, 0.91)
Gender 0.03 0.10 0.12 0.70 1.03 (0.81, 1.30)
Education level 0.05 0.10 0.24 0.62 0.93 (0.70, 1.20)
Marital status 0.30 0.09 5.92 0.007 1.30 (1.06, 1.58)
Having children 0.09 0.11 0.80 0.32 0.87 (0.69, 1.11)
Employment status 0.20 0.12 3.29 0.07 1.19 (0.97, 1.51)
Living with family 0.07 0.11 0.29 0.59 1.05 (0.83, 1.33)
Average monthly income (past 12 months) (Chinese yuan) 0.01 0.08 0.01 0.90 0.98 (0.85, 1.12)
Chronic disease 0.08 0.10 0.26 0.65 1.08 (0.91, 1.29)
Initial drug use age (years) 0.07 0.07 1.82 0.18 0.90 (0.80, 1.02)
Drug use over the past month 0.08 0.11 0.60 0.43 0.91 (0.72, 1.15)
Good family relationship 0.11 0.10 1.09 0.28 1.10 (0.87, 1.40)
Routine contact with friends 0.05 0.11 0.29 0.60 1.05 (0.86, 1.31)
Family/friends who support MMT 0.24 0.12 3.26 0.07 1.25 (0.97, 1.61)
Readmission 0.29 0.08 10.50 0.00 0.74 (0.61, 0.88)
Past treatment time (days) 0.07 0.03 7.25 0.01 0.92 (0.86, 0.98)
Good perceived social support 0.24 0.10 5.67 0.01 1.21 (1.08, 1.47)
Notes: * Value of covariates: age (years:  30 ¼ 1, 31e40 ¼ 2, 41e50 ¼ 3, >50 ¼ 4); gender (male ¼ 1, female ¼ 2); education level (primary and below ¼ 1, secondary ¼ 2,
tertiary ¼ 3); marital status (married ¼ 1, others ¼ 2); having children (yes ¼ 1, no ¼ 2); employment status (unemployed ¼ 1, employed ¼ 2); living with family (yes ¼ 1,
no ¼ 2); average monthly income (past 12 months; Chinese yuan: <1000 ¼ 1, 1000e3000 ¼ 2, >3000 ¼ 3); chronic disease (yes ¼ 1, no ¼ 2); initial drug use age (years:
20 ¼ 1, 21e30 ¼ 2, 31e40 ¼ 3, >40 ¼ 4); drug use over the past month (yes ¼ 1, no ¼ 2); good family relationship (yes ¼ 1, no ¼ 2); routine contact with friends (yes ¼ 1,
no¼ 2); family/friends who support MMT (yes¼ 1, no¼ 2); readmission (yes¼ 1, no¼ 2); past treatment time (days: <365¼ 1, 365e729¼ 2, 730e1094¼ 3, 1095e1459¼ 4,
1460 ¼ 5); and good perceived social support (yes ¼ 1, no ¼ 2). Outcome (Y): drop-off ¼ 1; until the end of follow-up ¼ 0. Time (t): actual days of MMT from April 1, 2012 to
March 31, 2014.
K.-N. Zhou et al. / Chinese Nursing Research 3 (2016) 11e1514reported positive effects of MMT on improving good patient-family
relationships in patients,26 this does notmean that the patients also
had higher levels of perceived social support. As perceived social
support has been deﬁned as beliefs about one's self-worth and the
availability and responsiveness of others,23 patients' perceptions of
social support during MMT should be considered.
By the end of follow-up, over 40% of the patients had terminated
MMT, indicating poor retention in MMT. Regardless of their base-
line characteristics and past retention history, the patients who didnot report good perceived social support were more likely to
terminate treatment than those with good perceived social sup-
port, suggesting that good perceived social support is a strong
protective predictor of retention. These results support the second
hypothesis that perceived social support predicts retention. The
likely explanation behind this relationship is that patients with
good perceived social support have relatively functional beliefs
about their self-worth and the availability and responsiveness of
others, which is helpful in retaining conﬁdence in MMT.10,23
K.-N. Zhou et al. / Chinese Nursing Research 3 (2016) 11e15 15Perceived social support should therefore be considered in reten-
tion management and interventions in MMT clinical practice.
This study had several limitations. First, the baseline informa-
tion collected did not cover all of the relevant patient characteris-
tics. For example, subjective variables regarding patients'
psychological status were not included in this cross-sectional sur-
vey. Second, the patients participating in the two-year follow-up
were not newly admitted. Thus, the inﬂuence of perceived social
support on MMT retention might be confounded by other potential
factors. A prospective follow-up study with newly admitted MMT
patients is needed to further clarify the relationship between
perceived social support and retention. Third, this study was con-
ducted in Xi'an, which limits the generalization of the results to all
MMT patients.
Based on the results of this study, retention does not signiﬁ-
cantly inﬂuence perceived social support, whereas good perceived
social support is a strong protective predictor of retention in MMT.
It is therefore recommended that perceived social support be
considered when developing retention management and inter-
vention programs in MMT patient populations.
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